Article
Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target.
BMC cancer - 10 Mar 2017
Roberts Cai M, Shahin Sophia A, Loeza Joana, Dellinger Thanh H, Williams John C, Glackin Carlotta A
Abstract excerpt
BACKGROUND: Most cancer deaths result from tumor cells that have metastasized beyond their tissue of origin, or have developed drug resistance. Across many cancer types, patients with advanced stage disease would benefit from a novel therapy preventing or reversing these changes. To this end, we have investigated the unique WR domain of the transcription factor TWIST1, which has been shown to play a role in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
